| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| orange book rating na | 1.09 | 0.4 | 8615 | 76 | 21 |
| orange | 0.32 | 0.2 | 6996 | 93 | 6 |
| book | 1.04 | 0.5 | 7370 | 97 | 4 |
| rating | 0.25 | 0.9 | 6641 | 34 | 6 |
| na | 0.06 | 0.3 | 6339 | 21 | 2 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| orange book rating na | 0.93 | 0.1 | 3663 | 39 |
| orange book rating a2 | 0.79 | 0.7 | 9714 | 29 |
| orange book rating ab | 1.14 | 0.6 | 5980 | 21 |
| orange book rating ap | 0.14 | 0.7 | 6152 | 23 |
| orange book nr rating | 1.97 | 0.4 | 923 | 51 |
| orange book at rating | 0.31 | 0.8 | 9782 | 43 |
| orange book za rating | 1.63 | 0.1 | 6518 | 86 |
| what is orange book rating | 1.69 | 0.4 | 8414 | 18 |
| orange book ratings explained | 1.93 | 0.6 | 3750 | 12 |
| orange book aa rating | 0.68 | 0.2 | 1832 | 19 |
| orange book rating codes | 0.68 | 0.7 | 9199 | 69 |
| orange book ab ratings | 1.99 | 0.6 | 7038 | 85 |
| orange book rating zb | 1.63 | 0.7 | 1615 | 14 |
| ab rated orange book | 0.15 | 0.6 | 5109 | 24 |
| orange book ab rating meaning | 2 | 0.1 | 7679 | 95 |
| orange book rating zc | 0.46 | 0.6 | 7564 | 95 |
| orange book ap rated | 1.78 | 0.8 | 1917 | 38 |
| orange book a rated generic | 0.55 | 0.6 | 7109 | 98 |
| orange book zb rated | 1.34 | 0.1 | 2120 | 48 |
Preface to the 41st Edition The publication, Approved Drug Products With Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the FD&C Act).
What are the Therapeutic Equivalence Evaluations in the Orange Book?The therapeutic equivalence evaluations in the Orange Book reflect FDA's application of specific criteria to the multisource prescription drug products listed in the Orange Book and approved under Section 505 of the FD&C Act. These evaluations are presented in the form of code letters that indicate the basis for the evaluation made.
When is the Orange Book Report on marketing status due?One-time report on marketing status for all ANDAs and NDAs required by FDARA section 506I (c) was due February 14, 2018. More information For more information, including the descriptions of data fields in the Orange Book Search, see Orange Book Data Files. Pre-Hatch-Waxman Abbreviated New Drug Applications (PANDA) in the Orange Book
How do I report an error or discrepancy in Orange Book data?We've updated our mobile app! The Orange Book downloadable data files are updated monthly. We make every effort to prevent errors and discrepancies in the Approved Drug Products data files. If you wish to report an error or discrepancy in drug data, please send a brief description of the problem to: [email protected]
